Chemotherapy with hybrid liposomes and application to drug delivery system with hybrid liposomes
Chemotherapy with hybrid liposomes and application to drug delivery system with hybrid liposomes
批准号:
17360403
负责人:
UEOKA Ryuichi
金额:
$10.48万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007
中文摘要
我们制备了一种杂化脂质体(HL),它可以通过在缓冲溶液中对囊泡和胶束分子进行超声处理来制备。通过改变HL的组分和组成比,可以控制HL的尺寸、形状、膜流动性和相分离温度等物理性质。我们使用HL进行癌症研究,有趣的结果如下:(A)通过电子显微镜和动态光散射测量,揭示了二myristoylphosphatidycholine (DMPC)和聚氧乙烯(23)-十二烷基醚(C12 (E0) 2)组成的直径为80 nm的HL均匀稳定的结构。(B) HL对人B淋巴瘤(RAJI)细胞的生长有明显的抑制作用。采用流式细胞术、DNA琼脂糖凝胶电泳、TUNEL显微摄影和延时视频观察HL对细胞凋亡的诱导作用。(C)在不使用任何药物的情况下,用HL治疗小鼠肿瘤模型后,存活时间明显延长,肿瘤体积明显减小。(D)在慢性毒性试验的基础上,给药后正常大鼠的血液检查、血液化学、相对脏器重量和尸检均未见异常。(E)在临床应用中,淋巴瘤患者静脉注射HL后可延长生存期,无任何副作用,局部给药混合脂质体后可显著减少肿瘤。(F) HL对体外培养的人外周血单个核细胞有明显的免疫刺激作用。(G)研究了一种庆大霉素治疗杜氏肌营养不良的新方法。庆大霉素包封HL对Mdx小鼠无毒性作用,并观察了庆大霉素包封HL对Mdx小鼠肌营养不良蛋白阳性纤维的影响。
英文摘要
We have produced hybrid liposomes (HL) which can be prepared by sonication of vesicular and micellar molecules in a buffer solution. The physical properties of HL such as size, shape, membrane fluidity, and the temperature of phase separation can be controlled by changing the constituents and compositional ratio. We have employed HL for the research of cancers and interesting results are as follows;(A) The uniform and stable structure of HL composed of dimyristoylphosphatidylcholine (DMPC) and polyoxyethylene (23)-dodecyl ether (C12 (E0) 2) with a diameter of 80 nm was revealed on the basis of electron microscopy and dynamic light scattering measurements.(B) The remarkable inhibitory effects of HL on the growth of human-B-lymphoma (RAJI) cells were attained. Induction of apoptosis by HL was obtained using flow cytometry, DNA agarose gel electrophoresis, micrograph with TUNEL method and time-laps video.(C) Significantly prolonged survival and remarkable reduction of tumor volume were obtained using mice model of carcinoma after the treatment with HL without any drug.(D) There were no abnormal findings on blood test, hemato chemistry, relative organ weight and autopsy of normal rats after administering HL on the basis of chronic toxicity tests.(E) In clinical applications, prolonged survival was attained in patients with lymphoma after the intravenous injection of HL without any side effect and remarkable reduction of neoplasm was obtained after the local administration of hybrid liposomes.(F) Remarkable immunostimulation effects of HL on human peripheral blood mononuclear cells were obtained in vitro.(G) A novel approach of gentamicin therapy for Duchenne Muscular Dystrophy using HL was examined. Mdx mice treated with gentamicin encapsulated HL did not show toxicity and the efficiency of dystrophin positive fibers in the mdx mice injected with gentamicin encapsulated HL was obtained.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Bionics
仿生学
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[前田礼男, 穂積俊矢, 谷口喜一郎, 松野健治]
通讯作者:
松野健治
DOI:
10.1016/j.bmcl.2006.08.099
发表时间:
2006-12-01
期刊:
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
影响因子:
2.7
作者:
[Komizu, Yuji, Matsumoto, Yoko, Ueoka, Ryuichi]
通讯作者:
Ueoka, Ryuichi
Diagnostic Application for Cancer Using Hybrid Liposomes Containing Fluorescent Labeling Lipids
使用含有荧光标记脂质的混合脂质体在癌症诊断中的应用
DOI:
--
发表时间:
2008
期刊:
影响因子:
--
作者:
[Nagata Miho, Osamu Tanoue, Yoko Matsumoto, Ryuichi Ueoka]
通讯作者:
Ryuichi Ueoka
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Kazuki Tatsumi, Yuji Komizu, Yoko Matsumoto, Ryuichi Ueoka, 巽 一喜, Hideaki Ichihara]
通讯作者:
Hideaki Ichihara
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Hideaki Ichihara, Yoko Matsumoto, Ryuichi Ueoka, Hideaki Ichihara, Hideaki Ichihara, Yuji Komizu]
通讯作者:
Yuji Komizu
共 84 条
Medical technological study of nano chemotherapy using hybrid liposomes for the refractory disease
-
批准号:25289299
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.15万
-
财政年份:2013
-
负责人:UEOKA Ryuichi
-
依托单位:
Basic and applied study on AIDS-therapy using hybrid liposomes
-
批准号:24656509
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.58万
-
财政年份:2012
-
负责人:UEOKA Ryuichi
-
依托单位:
Development of Nanotherapy System for Intractable Disease with Hybrid Liposomes-Cancer therapy with hybrid liposomes-
-
批准号:20360377
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.4万
-
财政年份:2008
-
负责人:UEOKA Ryuichi
-
依托单位:
Explanation of the Anticancer Mechanism and Clinical Chemotherapy for Hybrid Liposomes
-
批准号:14350439
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.22万
-
财政年份:2002
-
负责人:UEOKA Ryuichi
-
依托单位:
Antitum of Mechanism of Hybrid Liposomes and Clinical Application
-
批准号:12555232
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.4万
-
财政年份:2000
-
负责人:UEOKA Ryuichi
-
依托单位:
Functional Molecular Assemblies Coupled to Steric Control with High Enantioselectivity
-
批准号:07650968
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1995
-
负责人:UEOKA Ryuichi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
-
批准号:82304565
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:李瑾
-
依托单位:
基于Notch-1介导miR-200家族调控上皮间质转化对绒癌耐药机制的研究
-
批准号:81972428
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:安瑞芳
-
依托单位:
地塞米松诱导的人卵巢癌对化疗药物耐受及其机制的研究
-
批准号:81172471
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2011
-
负责人:陈玉霞
-
依托单位:
维生素B3促进化疗导致粒细胞减少症的中性粒细胞生成功能及作用机制研究
-
批准号:81060045
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:蓝丹
-
依托单位:
番荔枝内酯抗肿瘤作用及调节肿瘤耐药分子调控网络研究
-
批准号:30973854
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2009
-
负责人:欧阳学农
-
依托单位:
应用蛋白敲除技术降解ErbB家族的抗乳腺癌作用及其机制研究
-
批准号:30901754
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2009
-
负责人:李慧
-
依托单位:
卵巢癌肿瘤干细胞特异性microRNA分子靶点调控的研究
-
批准号:30873011
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2008
-
负责人:沈铿
-
依托单位:
巨噬细胞诱导的大肠癌靶向治疗实验研究
-
批准号:30471998
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2004
-
负责人:张继民
-
依托单位: